Literature DB >> 21887463

Transcriptional analysis of CXCR4, DNMT3A, DNMT3B and DNMT1 gene expression in primary advanced uterine cervical carcinoma.

Michał W Luczak1, Andrzej Roszak, Piotr Pawlik, Helena Kędzia, Witold Kędzia, Blanka Malkowska-Walczak, Margarita Lianeri, Paweł P Jagodziński.   

Abstract

The development of cervical cancer requires genetic and epigenetic factors which result in the persistence of a malignant phenotype. Cervical cancer exhibits also some unique differences from other solid tumors. Normal cervical stratified epithelia have characteristics of hypoxic tissue with over-expression of HIF-1 (hypoxia-inducible factor-1) transcription factor, which targets the transcription of over 70 genes involved in many aspects of cancer biology. One of the genes, which could be induced by HIF-1 is chemokine (C-X-C motif) receptor 4 (CXCR4). CXCR4 could also be epigenetically regulated by methylation of CpG dinucleotides located in the promoter region. Here, we examined the CXCR4, DNMT3A, DNMT3B and DNMT1 transcript levels in cancer tissue (n=30) and non-cancer, normal uterine cervical tissue (n=30) from a Polish cohort. We also compared the methylation status of CXCR4 promoter region in cancer and normal tissue samples. Our result showed significantly higher levels of CXCR4, DNMT3A, DNMT3B and DNMT1 transcript (p=0.0058, 0.0163, 0.0003 and <0.0001, respectively) levels in cancer tissue as compared to normal samples. We did not observe DNA methylation in the CXCR4 promoter region in either control or cancer tissue samples. CXCR4 has a functional hypoxia response element (HRE) in the promoter region, located -1.3 kb from the transcription start site. Our work shows for the first time that HIF-1A could promote the induction of CXCR4 gene expression (Spearman's correlation coefficient = 0.515, p=0.003) in patients with primary advanced uterine cervical carcinoma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21887463     DOI: 10.3892/ijo.2011.1183

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  9 in total

1.  p16 hypermethylation: a biomarker for increased esophageal cancer susceptibility in high incidence region of North East India.

Authors:  Mandakini Das; Bhaskar Jyoti Saikia; Santanu Kumar Sharma; Gaganpreet Singh Sekhon; Jagadish Mahanta; Rup Kumar Phukan
Journal:  Tumour Biol       Date:  2014-11-01

Review 2.  Embryonic stem cell-specific signature in cervical cancer.

Authors:  Jorge Organista-Nava; Yazmín Gómez-Gómez; Patricio Gariglio
Journal:  Tumour Biol       Date:  2013-10-28

3.  The 46359CT polymorphism of DNMT3B is associated with the risk of cervical cancer.

Authors:  Daniel Hernández-Sotelo; Rubén García-Aguilar; Yaneth Castro-Coronel; Jonathan J Magaña; Marco Antonio Leyva-Vazquez; Luz del Carmen Alarcón-Romero; Esther López-Bayghen; Berenice Illades-Aguiar
Journal:  Mol Biol Rep       Date:  2013-05-16       Impact factor: 2.316

4.  Candidate biomarkers for cervical cancer treatment: Potential for clinical practice (Review).

Authors:  Miho Iida; Kouji Banno; Megumi Yanokura; Kanako Nakamura; Masataka Adachi; Yuya Nogami; Kiyoko Umene; Kenta Masuda; Iori Kisu; Takashi Iwata; Kyoko Tanaka; Daisuke Aoki
Journal:  Mol Clin Oncol       Date:  2014-06-23

Review 5.  A meta-analysis for CXCR4 as a prognostic marker and potential drug target in non-small cell lung cancer.

Authors:  Changyuan Zhang; Jie Li; Yi Han; Jian Jiang
Journal:  Drug Des Devel Ther       Date:  2015-06-24       Impact factor: 4.162

6.  Epigenetic silencing of CXCR4 promotes loss of cell adhesion in cervical cancer.

Authors:  Suresh Singh Yadav; Shyam Babu Prasad; Mitali Das; Soni Kumari; Lakshmi Kant Pandey; Sunita Singh; Satyajit Pradhan; Gopeshwar Narayan
Journal:  Biomed Res Int       Date:  2014-07-10       Impact factor: 3.411

7.  Islet-1 induces the differentiation of mesenchymal stem cells into cardiomyocyte-like cells through the regulation of Gcn5 and DNMT-1.

Authors:  Qin Yi; Hao Xu; Ke Yang; Yue Wang; Bin Tan; Jie Tian; Jing Zhu
Journal:  Mol Med Rep       Date:  2017-03-16       Impact factor: 2.952

8.  Limited Role of Promoter Methylation of MGMT and C13ORF18 in Triage of Low-Grade Squamous Intraepithelial Lesion.

Authors:  Lu-Lu Sun; Yuan Liu; Xiao Sun; Lei Pan; Dan Wu; Yu-Dong Wang
Journal:  Chin Med J (Engl)       Date:  2018-04-20       Impact factor: 2.628

9.  Downregulation of miR-199a-5p promotes prostate adeno-carcinoma progression through loss of its inhibition of HIF-1α.

Authors:  Jinjing Zhong; Rui Huang; Zhengzheng Su; Mengni Zhang; Miao Xu; Jing Gong; Ni Chen; Hao Zeng; Xueqin Chen; Qiao Zhou
Journal:  Oncotarget       Date:  2017-05-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.